From: A retrospective study of the role of hypercapnia in patients with acromegaly
Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Hypercapnia | 0.61 (0.24–1.58) | 0.31 | - | - |
BMI > 25 | 0.90 (0.37–2.20) | 0.824 | - | - |
Age > 40 | 1.13 (0.48–2.61) | 0.784 | - | - |
Duration of symptoms | 1.06 (0.98–1.14) | 0.132 | - | - |
Male | 0.45 (0.19–1.05) | 0.063 | - | - |
DM | 2.59 (1.02–6.55) | 0.045 | 3.29 (1.15–9.46) | 0.027 |
Hypertension | 0.84 (0.37–1.93) | 0.679 | - | - |
Current smoking | 1.88 (0.55–6.42) | 0.314 | - | - |
LSpO2 | 1.04 (0.99–1.09) | 0.088 | - | - |
ODI | 0.99 (0.97–1.01) | 0.137 | - | - |
T90 | 0.97 (0.93–1.00) | 0.059 | - | - |
AHI > 30/h | 0.43 (0.17–1.05) | 0.063 | - | - |
Preoperative pharmacotherapy | 0.21 (0.06–0.79) | 0.020 | 0.21 (0.06–0.83) | 0.034 |
TSH | 0.53 (0.32–0.88) | 0.013 | - | - |
Total cortisol | 0.93 (0.86–1.00) | 0.057 | - | - |
Prolactin | 1.02 (0.99–1.04) | 0.182 | - | - |